In fact, the pharmacological activation of CB1r, the inhibition of eCB degradative enzyme fatty acid amide
hydrolase (FAAH) and the blockade of eCB re-uptake attenuated anxiety parameters using different procedures in rodents [3,4] and humans [e.g., 19].